These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9339959)

  • 1. Apoptosis: clinical relevance and pharmacological manipulation.
    Thatte U; Dahanukar S
    Drugs; 1997 Oct; 54(4):511-32. PubMed ID: 9339959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: Apoptosis.
    Kataoka S; Tsuruo T
    Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of granulocyte apoptosis by hemopoietic growth factors, cytokines and drugs: potential relevance to allergic inflammation.
    Walker A; Ward C; Dransfield I; Haslett C; Rossi AG
    Curr Drug Targets Inflamm Allergy; 2003 Dec; 2(4):339-47. PubMed ID: 14561153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
    Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
    Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between SCF or M-CSF with IL-3 or GM-CSF in FDC-P1 cells: a sensitive assay of transforming mutations of c-fms.
    Baker DA; Glover HR; Dibb NJ
    Leukemia; 1994 Jan; 8(1):141-50. PubMed ID: 7507191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor.
    Kobayashi SD; Voyich JM; Whitney AR; DeLeo FR
    J Leukoc Biol; 2005 Dec; 78(6):1408-18. PubMed ID: 16204629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in health and disease.
    Singh N; Anand S
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):91-4. PubMed ID: 7649613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical toxicity of cytokines used as haemopoietic growth factors.
    Vial T; Descotes J
    Drug Saf; 1995 Dec; 13(6):371-406. PubMed ID: 8652081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells.
    Stahnke K; Hecker S; Kohne E; Debatin KM
    Exp Hematol; 1998 Aug; 26(9):844-50. PubMed ID: 9694505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and toxicity of the colony-stimulating factors.
    Schriber JR; Negrin RS
    Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of hematopoietic growth factors on human breast epithelial cell growth in serum-free primary culture.
    Emerman JT; Eaves CJ
    Bone Marrow Transplant; 1994 Mar; 13(3):285-91. PubMed ID: 7515301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors.
    Metcalf D
    Stem Cells; 1993 Jul; 11 Suppl 2():1-11. PubMed ID: 7691313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF).
    Caruana G; Ashman LK; Fujita J; Gonda TJ
    Exp Hematol; 1993 Jun; 21(6):761-8. PubMed ID: 7684700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumour necrosis factor receptor, increasing susceptibility to tumour necrosis factor-induced apoptosis. Control of leukaemia cell life/death switching.
    Rae C; MacEwan DJ
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S162-71. PubMed ID: 15459750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.